New inhaler tested for lung disease
NCT ID NCT07331402
Summary
This study is testing a new inhaled medication called HSK39004 for people with COPD, a chronic lung disease. It will measure how much of the drug gets into the bloodstream and how it affects patients' breathing over 12 hours. The study involves 12 participants who will try both the new drug and a standard medication in a random order.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COPD PATIENTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
36 Sanhao Street, Heping District, Shenyang, Liaoning,China
Shenyang, Liaoning, China
Conditions
Explore the condition pages connected to this study.